The 5-Second Trick For "3
All enrolled people who obtained at the least a person dose of zosuquidar or placebo through induction were being monitored for your event of adverse situations (439 people, 219 on zosuquidar and 210 on placebo). The commonest adverse occasions have been relevant to the duration of extended and sizeable myelosuppression as is expected with inductio